Using Virtual Reality and Robotics Technologies for Vocational Evaluation, Training and Placement

NCT02498262 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2019-07-12

No results posted yet for this study

Summary

Using Virtual Reality and Robotics Technologies for Vocational Evaluation, Training and Placement (VR4VR) is a project that incorporates Virtual Reality into job training to increase job opportunities for people who have physical or mental disabilities. The investigators are using Virtual Reality and robotics for job evaluation, training and placement of people with disabilities. The investigators' goal is to assess and train people in a safe, adaptable, and fun virtual environment similar to a video game.

This is an interventional study with three target populations: autism spectrum disorder, traumatic brain injury, and severe mobility and manipulation impairments. The prototype system allows for a wide range of environments with the vocational evaluator easily controlling the virtual experience, while the job seekers interact realistically.

Conditions

Interventions

OTHER

Virtual Reality System

The participants will use a virtual reality system that is like a large video game and complete some job skill tasks in the virtual world video game.

Sponsors & Collaborators

  • Florida Department Of Education

    collaborator OTHER_GOV
  • University of South Florida

    lead OTHER

Principal Investigators

  • Redwan Alqasemi, Ph.D. · University of South Florida

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2019-12-31
Completion
2020-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02498262 on ClinicalTrials.gov